CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
Clinical trial NCT04667663 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04667663
- Sponsor
- Cancer Trials Ireland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2022-04-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.